Sloan Sheldon
Spyre Therapeutics, Inc. · Chief Medical Officer
Sloan Sheldon is listed in filings as Chief Medical Officer at Spyre Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 3, 2026, including sale activity. Recent filings connect the profile to Spyre Therapeutics, Inc. (SYRE). The current snapshot covers public activity from Jan 13, 2026 to Jun 3, 2026. Reported amounts are shown as $4.3M to $625.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $625k8.3k shares | SellJun 3, 2026 | $75.00 | $98.95 |